Experimental Infection using Human Isolates of Blastocystis sp. in Dexamethasone Immunosurpressed Mice

Abstract

Blastocystis sp. is a controversial protozoan in terms of its pathogenic role associated with high-prevalence gastrointestinal disease. To evaluate signs, symptoms and laboratory findings produced by Blastocystis sp., dexamethasone immunosuppressed mice were infected with parasite morphologies obtained from symptomatic and asymptomatic patients. The parasites were isolated using density gradient with lymphoprep™, semi-quantification of the morphologies present in the stool sample was performed and 1.6 × 105 parasites were inoculated into Balb/c mice, intragastrically. In the faeces of symptomatic patients, vacuolar morphology was six times greater than granular morphology, whereas the ratio in asymptomatic patients was only two times greater. The most common symptoms in patients were flatulence (85%), headache (62%), abdominal pain (55%), fever (30%) and constipation (8%). The semi-quantification of parasites per field in humans evidenced no direct relationship between parasite burden and gastrointestinal symptoms, while in parasite quantification per gram of feces, a direct relationship was found. The mice showed variable signs after infection; all those infected with samples from symptomatic patients showed signs, while only some of those infected with samples from asymptomatic patients developed them. It was demonstrated that no statistically significant (p = 0.8) relationship exists between the morphology of the parasite and the signs manifested by the mouse; nevertheless, there was a statistically significant (p = 0.02) relationship between the vacuolar forms of the parasite and onset of symptoms in patients. Conclusions are that Blastocystis sp. is capable of producing signs suggestive of pathology in mice.

Keywords

• blastocystis sp
• infectividad
• virulencia.